主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HCWB
#4491
HCW Biologics Inc. Common Stock
0.398
9
USD
+6.92%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+6.92%
每月变动
-24.82%
6个月变化
-35.24%
年变化
-35.24%
前一天收盘价
0.373
1
Open
0.398
9
Bid
0.398
9
Ask
0.401
9
Low
0.398
9
High
0.398
9
交易量
8
市场
股票
医疗保健
HCWB
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
894.49 K
897.17 K
945.58 K
1.12 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
Price to book ratio
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.24
-0.32
-0.88
-0.99
-0.44
Return on equity %
-0.25
-0.4
-1.86
4.43
40.01
Return on invested capital %
-362.98
-419.93
-486.93
-221.71
—
Gross margin %
—
38.6
19.72
37.38
80
Operating margin %
—
-225.06
-904.96
-1 148.5
-113.6 K
EBITDA margin %
—
-214.67
-865.02
-1 102.36
—
Net margin %
—
-222.4
-879.52
-1 169.7
-102.84 K
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
17.44
11.52
0.73
0.19
0.43
Inventory turnover
—
—
—
—
—
Asset turnover
0
0.13
0.08
0.08
0.01
Solvency ratios
Debt to assets ratio
—
—
—
0.45
1.49
Debt to equity ratio
—
—
—
-2.02
-137.5
Long term debt to total assets ratio
—
0.14
0.22
0.24
0.55
Long term debt to total equity ratio
—
0.17
0.47
-1.09
-9.05
Per share metrics
Operating cash flow per share
—
-11.6
-25.06
-14.67
-6.28
EBIT per share
—
-16.86
-28.63
-30.4
-6.71
EBITDA per share
—
-16.06
-27.37
-29.18
—
Total debt per share
—
—
—
14.12
21.26
Cash per share
—
35.77
4.01
4.82
6.7
Net current asset value per share
—
38.04
7.13
5.88
8.25
Tangible book value per share
—
41.79
14.99
-6.98
-8.13
Working capital per share
—
34.74
-2.61
-24.67
-49.88
Book value per share
—
41.79
14.99
-6.98
-8.13
新闻
HCW Biologics从中国被许可方获得700万美元预付费用
HCW Biologics receives $7M upfront fee from China licensee
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.83%
美国股市上涨;截至收盘道琼斯工业平均指数上涨0.83%
HCW Biologics化合物在CAR-T细胞生产中展现前景
HCW Biologics’ compound shows promise in CAR-T cell production
HCW Biologics与中国Trimmune达成700万美元授权协议
HCW Biologics enters $7 million licensing deal with China-based Trimmune
HCW Biologics采取措施重获纳斯达克合规地位
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions
HCW Biologics通过权证行权协议获得400万美元资金
HCW Biologics secures $4 million through warrant exercise agreement